We calculated a ratio of albumin-binding probe enhancement (CNR) of the aneurysm wall to the size of nonenhancing thrombus area, which allowed us to predict AAA rupture with high sensitivity and specificity. This evidence concerns the gene ALB and triple-A syndrome.